Skip to Main Content

An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

View 0 Studies Requested

Browse Lab Results > 2016-0018

Trial Summary

About CDAS Project, PI, Publications: Validation of serum autoantibody for pancreatic cancer early detection

Datasets


Site: Pancreas

Inclusion Criteria:

  • No Prior History of Pancreatic Cancer
  • Cancer Free Non-Cases
  • Valid DQX
  • Has Serum Material
  • Has 200ul Most Proximal Pre-DX Serum Within 5 Years of DX
  • Matched at a 5-1 Ratio

Matching Factors:

  • Gender
  • Age at Randomization (5 year intervals)
  • Race (W/B/O)
  • Fiscal Year of Randomization (2 year groups with first group being 3 years)
  • Year of Blood Draw

Match Ratio: 5 to 1

Match Technique: Individual matching only non-cases as controls.

Additional Matching Comments: Two non-cases desired year of draw were altered to handle match deficiencies.


Analytes:

  • Anterior Gradient 2
  • Cancer Antigen 19-9
  • Carcinoembryonic antigen
  • DIACETYLSPERMINE
  • Indole-derivative
  • Leucine Rich Alpha-2-Glycoprotein 1
  • Lysophosphatidylcholine(18:0)
  • Lysophosphatidylcholine(20:3)
  • N8-ACETYLSPERMIDINE
  • Regenerating Family Member 3 Alpha
  • TIMP Metallopeptidase Inhibitor 1

Number of Cases: 175

Number of Controls: 875